Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

Business Leaders

HomeAll NewsMost read newsBusiness Leaders Biography 
Portrait de Robert Landry
Age : 58
Public asset : 25,795,188 USD
Country of residence : Unknown
Linked companies : Regeneron Pharmaceuticals, Inc. - Checkmate Pharmaceuticals, Inc.

Biography of Robert Landry 
Robert E. Landry is Chief Financial Officer & Executive VP-Finance at Regeneron Pharmaceuticals, Inc. He previously was Treasurer & Senior Vice President at Pfizer Inc. Director-Pharmaceutical Marketing & Sales at Wyeth Australia Pty Ltd. Chief Financial Officer of Wyeth New Zealand and Treasurer & Principal Corporate Officer at Wyeth Corp. (which are all subsidiaries of Pfizer Inc.). Mr. Landry received an undergraduate degree from the University of Notre Dame.


Current positions of Robert Landry 
Holdings of Robert Landry 
Robert Landry : Personal Network 
Most Read News 
05/22Bill Gates says top AI agent poised to replace search, shopping businesses
RE
05/15Debt ceiling jitters, Turkey vote, Soros ditches Tesla
RE
05/16Capital One shares up after billionaire investor Buffett's near $1 billion bet on bank
RE
05/17EV maker Fisker is exploring collaboration with other companies, CEO says
RE
05/25Elon Musk's Neuralink gets U.S. FDA approval for human clinical study of brain implants
RE
05/25BOE Rate Rise of More Than 25Bps Looks Unlikely
DJ
05/26JPMorgan CEO Dimon denies personal connections with Epstein
RE
05/19Ferrari boss pitted against his mother in Agnelli inheritance drama
RE
05/15TSMC added by Macquarie, Fidelity and Coatue after Buffett cut stake -filings
RE
05/23Drahi increases stake in BT to 24.5%
RE
More news


© 2023 People and Ownership :   
Robert Landry : Connections 


Latest news about Robert Landry 
05/09Transcript : Regeneron Pharmaceuticals, Inc. Presents at Bank of America Securities 2023 Healthcare Conference, May-09-2023 01:40 PM
CI
05/04Transcript : Regeneron Pharmaceuticals, Inc., Q1 2023 Earnings Call, May 04, 2023
CI
03/15Transcript : Regeneron Pharmaceuticals, Inc. Presents at Barclays Global Healthcare Conference, Mar-15-2023 09:00 AM
CI
02/03Transcript : Regeneron Pharmaceuticals, Inc., Q4 2022 Earnings Call, Feb 03, 2023
CI
2022Transcript : Regeneron Pharmaceuticals, Inc. Presents at Piper Sandler 34th Annual Healthcare Conference, Nov-30-2022 08:00 AM
CI
2022Transcript : Regeneron Pharmaceuticals, Inc. Presents at 13th Annual Jefferies London Healthcare Conference 2022, Nov-16-2022 03:15 PM
CI
2022Transcript : Regeneron Pharmaceuticals, Inc., Q3 2022 Earnings Call, Nov 03, 2022
CI
More news

-40% off: Our subscriptions help you unlock hidden opportunities!
Subscribe
fermer